BML Capital Management
Latest statistics and disclosures from BML Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACRS, AVIR, ORMP, TIL, PMVP, and represent 79.85% of BML Capital Management's stock portfolio.
- Added to shares of these 8 stocks: KMX (+$6.0M), TGT, CVNA, OM, PLRX, TSLA, WMT, AVIR.
- Started 5 new stock positions in OM, PLRX, CVNA, KMX, TSLA.
- Reduced shares in these 10 stocks: ADVM (-$14M), ALMS, LVTX, CNTB, Athira Pharma, ASTC, VTGN, ARVN, MURA, LSTA.
- Sold out of its positions in ADVM, ALMS, ARVN, ASTC, Athira Pharma, THRD, VTGN, MURA, LVTX.
- BML Capital Management was a net seller of stock by $-13M.
- BML Capital Management has $116M in assets under management (AUM), dropping by 5.93%.
- Central Index Key (CIK): 0001616824
Tip: Access up to 7 years of quarterly data
Positions held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BML Capital Management
BML Capital Management holds 16 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 37.1 | $43M | 14M | 3.01 |
|
|
| Atea Pharmaceuticals (AVIR) | 23.1 | $27M | 7.5M | 3.57 |
|
|
| Oramed Pharmaceuticals Com New (ORMP) | 7.8 | $9.0M | 3.2M | 2.85 |
|
|
| Instil Bio Com New (TIL) | 6.1 | $7.1M | 646k | 11.00 |
|
|
| Pmv Pharmaceuticals (PMVP) | 5.7 | $6.6M | 5.3M | 1.25 |
|
|
| CarMax (KMX) | 5.2 | $6.0M | NEW | 155k | 38.64 |
|
| Kezar Life Sciences Com New (KZR) | 3.9 | $4.5M | 721k | 6.29 |
|
|
| Target Corporation (TGT) | 3.2 | $3.7M | +275% | 38k | 97.75 |
|
| Carvana Cl A Put Option (CVNA) | 1.7 | $2.0M | NEW | 150.00 | 13440.00 |
|
| Outset Med Com New (OM) | 1.7 | $2.0M | NEW | 543k | 3.71 |
|
| Pliant Therapeutics (PLRX) | 1.6 | $1.9M | NEW | 1.5M | 1.22 |
|
| Imagenebio (IMA) | 1.1 | $1.2M | -3% | 177k | 6.90 |
|
| Connect Biopharma Hldgs SHS (CNTB) | 1.0 | $1.2M | -67% | 409k | 2.82 |
|
| Wal-Mart Stores Put Option (WMT) | 0.4 | $493k | +26% | 335.00 | 1470.00 |
|
| Tesla Motors Put Option (TSLA) | 0.2 | $205k | NEW | 1.0k | 205.00 |
|
| Lisata Therapeutics (LSTA) | 0.1 | $136k | -33% | 73k | 1.86 |
|
Past Filings by BML Capital Management
SEC 13F filings are viewable for BML Capital Management going back to 2022
- BML Capital Management 2025 Q4 filed Feb. 3, 2026
- BML Capital Management 2025 Q3 filed Nov. 10, 2025
- BML Capital Management 2025 Q2 filed Aug. 11, 2025
- BML Capital Management 2025 Q1 filed May 7, 2025
- BML Capital Management 2024 Q4 filed Feb. 7, 2025
- BML Capital Management 2024 Q3 filed Nov. 5, 2024
- BML Capital Management 2024 Q2 filed Aug. 7, 2024
- BML Capital Management 2024 Q1 restated filed April 24, 2024
- BML Capital Management 2024 Q1 filed April 23, 2024
- BML Capital Management 2023 Q4 restated filed Feb. 2, 2024
- BML Capital Management 2023 Q4 filed Jan. 30, 2024
- BML Capital Management 2023 Q3 filed Oct. 23, 2023
- BML Capital Management 2023 Q2 filed July 24, 2023
- BML Capital Management 2023 Q1 filed April 14, 2023
- BML Capital Management 2022 Q4 filed Feb. 13, 2023